US Patent 11713321 Inhibitors of NEK7 kinase
Patent 11713321 was granted and assigned to Halia Therapeutics, Inc. on August, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 14, 2021
0
Date of Patent
August 1, 2023
0
Patent Applicant
Patent Application Number
17475220
0
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11713321 Inhibitors of NEK7 kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
